Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

The CORE Institute Specialty Hospital Adopts Xenex UV Disinfection Based on Clinical Evidence

Xenex Disinfection Services
Posted on: 21 Aug 17

The CORE Institute Specialty Hospital®, a world leader in orthopedic care, announced it has expanded its infection prevention program at its hospital to include pulsed xenon ultraviolet (UV) room disinfection. After carefully evaluating the clinical evidence, hospital leadership chose the Xenex LightStrike® Germ-Zapping Robot® to disinfect its Operating Rooms (ORs) and patient rooms. It will also disinfect ORs between cases for all orthopedic and joint replacement procedures.

The CORE Institute Specialty Hospital is a physician-owned hospital and already has one of the lowest surgical site infection (SSI) rates in Arizona. The hospital leadership and clinical staff made the decision to stay at the forefront of evidence-based care and expand its cleaning protocol to include pulsed xenon UV room disinfection. The Xenex LightStrike pulsed xenon UV robot is proven to quickly destroy the germs and bacteria that cause SSIs. LightStrike Robots help hospitals like The CORE Institute Specialty Hospital reduce their infection rates by killing the microscopic pathogens that may be missed during the manual cleaning process.

"Our goal is to do everything possible to optimize safety for our patients. The clinical data, coupled with our commitment to reducing infection risk, drove our decision to deploy a Xenex robot at The CORE Institute Specialty Hospital,” said David Jacofsky, MD, chief executive officer and chairman of The CORE Institute.

Xenex’s germ fighting robots use pulsed xenon, an environmentally-friendly noble gas, to create Full Spectrum™, high intensity UV light that quickly destroys infectious germs in less than five minutes. The portable disinfection system is effective against even the most dangerous pathogens, including Clostridium difficile (C.diff), carbapenem-resistant Enterobacteriaceae (CRE), norovirus, Methicillin-resistant Staphylococcus aureus (MRSA), influenza and the Ebola virus. Hospitals using Xenex devices have published outcome studies in peer-reviewed journals showing 50-100 percent decreases in C.diff, MRSA and Surgical Site Infection rates when those hospitals used the Xenex Robots to disinfect rooms.

“People travel from all over the world to receive care at The CORE Institute Specialty Hospital and we are honored that The CORE Institute Specialty Hospital has selected our room disinfection technology to supplement their infection prevention practices,” said Joseph Authement, senior vice president of global sales at Xenex. “The CORE Institute Specialty Hospital is continually on the forefront of innovation and recognized for programs and protocols that enable them to deliver outstanding patient care while managing their costs effectively. Being selected to be part of their infection prevention program is a significant validation of our technology.”

About Xenex Disinfection Services

Xenex's patented Full Spectrum pulsed xenon UV room disinfection system is used for the advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. Xenex’s mission is to save lives and reduce suffering by destroying the deadly microorganisms that cause HAIs. The company is backed by well-known investors that include EW Healthcare Partners, Piper Jaffray Merchant Banking, Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures and RK Ventures. For more information, visit www.xenex.com.

About the CORE Institute Specialty Hospital:

The CORE Institute Specialty Hospital® is a surgical hospital specializing in spine and orthopedic surgical procedures. It opened in 2015 as a partnership between The CORE Institute and Surgical care Affiliates (SCA).

The CORE Institute Specialty Hospital is owned by physicians and meets the definition of a “physician-owned hospital” under 42 CFR 489.3. Inpatient and outpatient diagnostic imaging and laboratory services are provided also within the hospital’s license. The hospital, imaging and lab services are fully accredited by the Joint Commission.

The hospital is owned in part by physicians or an immediate family member of physicians. A list of the Hospital’s physician owners is immediately available upon request by or on behalf of the patient. Please request a copy from hospital administration at 50391admin@scasurgery.com, or by phone at 602-795-6020.

For more information about The CORE Institute Specialty Hospital, please visit www.thecoreinstitutehospital.com.

About The CORE Institute

The CORE Institute® was founded to fulfill a vision of excellence in patient care encompassing the entire spectrum of orthopedic and neurosciences care. The CORE Institute delivers integrated, comprehensive musculoskeletal and neurological care. They are built upon a foundation of pioneering research, academics, community service, and a passion for excellence in patient care. The organization continues to be a leader in payor-reform initiatives, and it is at the forefront of systems-based quality programs which drive value and improve the quality of patient care.

Connect with The CORE Institute at www.thecoreinstitute.com or on Facebook, Twitter, and YouTube.

About Surgical Care Affiliates

An industry leader, SCA partners with physicians, health systems and payers to develop and implement surgery strategies across the country. As of September 30, 2014, SCA operated 182 surgical facilities - including ambulatory surgery centers, surgical hospitals and eleven sleep centers - in partnership with approximately 2,000 physicians and in affiliation with 41 health systems across the country. SCA's clinical systems, service line growth strategies, benchmarking processes and efficiency programs create measurable advantage for surgical facilities - clinically, operationally and financially.

For more information on SCA, visit www.scasurgery.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170821005579/en/

Business Wire
www.businesswire.com

Last updated on: 21/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.